|
Sixth International CongressDrug Therapy in HIV Infection17-21 November, 2002
|
[ABSTRACT:] Nucleoside reverse transcriptase inhibitors (NRTIs) are anabolised intracellularly to their known corresponding active triphosphate (TP). This intracellular anabolism plays a critical role regarding both their efficacy and toxicity.
Using a newly developed direct LC/MS/MS technique [1,2], able to detect simultaneously the phosphorylated form of several NRTIs, we made the surprising observation that intracellular metabolism of AZT, well known to produce AZT-TP, systematically leads to the formation of d4T-TP, usually resulting of the intracellular anabolism of d4T. This seems strictly restricted to the intracellular anabolism of AZT since analysis of PBMCs from patients with therapy excluding both AZT and d4T never shown d4T-TP and, significant amount of d4T were not detected in the plasma of AZT-treated patients. Intracellular d4T-TP concentrations measured in AZT-treated patients represent between 3% and 37% of the corresponding AZT-TP concentrations and are in the lower range of d4T-TP concentrations measured in d4T-treated patients3, indicating that d4T-TP could participate to the antiretroviral activity and/or toxicity of AZT. This observation, also supported by in vitro experiments, brings a new light on the cross resistance observed between AZT and d4T.
Presenting author: Jacques Grassi
Download Conferences Abstracts
* CEA, Pharmacology and Immunology Unit, DSV/DRM, 91191 Gif-sur-Yvette Cedex
** Internal Medicine Unit, University Hospital of Bicêtre, Kremlin-Bicêtre, France
References
1 Pruvost A, et al. "Direct determination of phosphorylated intracellular anabolites of stavudine (d4T) by liquid chromatography/tandem mass spectrometry", Rapid Commun Mass Spectrom 2001;15(16):1401-8.
2 Becher F, et al. "Development of a direct assay for measuring intracellular AZT triphosphate in humans peripheral blood mononuclear cells", Anal Chem 2002 Aug 15;74(16):4220-7.
3 Becher F, et al. "Monitoring Intracellular Triphosphorylated Anabolites of Didanosine EC (ddI) and Stavudine (d4T): Results of a Pilot Clinical Study in HIV-Infected Patients", 9th CROI, Seattle, 2002. Abstract 452-W
2002-11-17
PL8-4
Copyright © 2002 - The Gardiner-Caldwell Group, Ltd.. All Rights Reserved. Reproduction of this abstract (other than one copy for personal reference) must be cleared through the Sixth International Congress on Drug Therapy in HIV Infection, c/o The Gardiner-Caldwell Group Ltd, part of The Thomson Corporation, Peakside House, Alder Court, Tytherington Business Park, Tytherington, Cheshire SK10 2XG, UK - Tel: +44 (0)1625 668000, Fax: +44 (0)1625 668121 Email: hiv6@gardiner-caldwell.com
This information is designed to support, not replace, the relationship that exists between you and your doctor. ©1980, 2005. AEGiS.